Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03421678

Ethnic/Racial Differences in Metabolism and DNA Adduct Formation

Ethnic/Racial Differences in Metabolism and DNA Adduct Formation by 1,3-butadiene

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Masonic Cancer Center, University of Minnesota · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The study will investigate the role of 1,3-butadiene metabolic activation and deactivation in lung cancer risk among various ethnic/racial groups. This project will require urine samples from smokers and nonsmokers from the three ethnic/racial groups recruited by the Clinical and Biomarker Core for the analysis of 1,3-butadiene DNA adducts. Data on nicotine intake (urinary TNE) in these subjects as well as in 400 lung cancer cases and 400 controls from Project 1 will be also required for this project.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUrine SampleOne to two home visits where tobacco use and medical history and biological samples will be collected including blood, buccal cells and urine

Timeline

Start date
2020-10-01
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2018-02-05
Last updated
2020-10-05

Source: ClinicalTrials.gov record NCT03421678. Inclusion in this directory is not an endorsement.